Brooks Laboratories Limited has appointed Rajesh Mahajan as President – Trading and Senior Management Personnel, effective July 17, 2026. The move places Mahajan at the helm of the company’s trading operations, a critical plank for Brooks’ growth strategy in the pharmaceutical arena.
Mahajan brings more than two decades of experience in the pharmaceutical industry, backed by a Bachelor’s degree in Biology and an MBA in Marketing. He has deep expertise in pharmaceutical formulations and manufacturing operations, a profile that aligns with Brooks’ emphasis on strengthened product development and market reach.
During his tenure at Brooks, he has been instrumental in the growth of the formulation business and played a key role in planning and executing new projects and business development initiatives. This internal elevation underscores the company’s focus on leveraging experienced leadership to drive its trading and commercial objectives.
Industry observers will likely view the appointment as a signal of Brooks’s ambition to sharpen its trading capabilities and broaden its footprint in a competitive market, as the company looks to capitalize on its formulation strengths and pursue new growth avenues.